The role of the gut-brain axis in alcohol use disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 65, Issue , 2016, Pages 234-241

  Gorky, Jonathan ^a   Schwaber, James ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Gut microbiome; Gut brain axis; Neuroinflammation; Vagus nerve; Withdrawal

Indexed keywords

ALCOHOL USE DISORDER; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; BEHAVIOR CHANGE; BRAIN FUNCTION; DYSBIOSIS; GUT BRAIN AXIS; HUMAN; INTESTINE FLORA; INTRACELLULAR SIGNALING; LIMBIC SYSTEM; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NONHUMAN; REVIEW; SENSORY NERVE; VAGUS NERVE; ANIMAL; BRAIN; DRUG EFFECTS; IMMUNOMODULATION; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ALCOHOL-RELATED DISORDERS; ANIMALS; BRAIN; GASTROINTESTINAL MICROBIOME; HUMANS; NEUROIMMUNOMODULATION;

EID: 84949534153     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.06.013     Document Type: Review

References (89)

1. Anders H.-J., Andersen K., Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. [Internet] 2013, 83(6):1010-1016. (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23325079).
2. Asai K., Buurman W.A., Reutelingsperger C.P.M., Schutte B., Kaminishi M. Low concentrations of ethanol induce apoptosis in human intestinal cells. Scand. J. Gastroenterol. Norway 2003, 38(11):1154-1161. (Nov).
3. Asan E., Yilmazer-Hanke D.M., Eliava M., Hantsch M., Lesch K.P., Schmitt A. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Neuroscience 2005, 131:953-967.
4. Banks W., Plotkin S., Kastin A. Permeability of the blood-brain barrier to soluble cytokine receptors. Neuroimmunomodulation 1995, 2(3):161-165.
5. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141:599-609.
6. Berk M., Williams L.J., Jacka F.N., O'Neil A., Pasco J.a, Moylan S., et al. So depression is an inflammatory disease, but where does the inflammation come from?. BMC Med. 2013, 11(1):200. BMC Med [Internet], (Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3846682&tool=pmcentrez&rendertype=abstract).
7. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(38):16050-16055. (Sep).
8. Bruce-Keller A.J., Salbaum J.M., Luo M., Blanchard E., Taylor C.M., Welsh D.A., Berthoud H.R. Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol. Psychiatry. 2015, 77(7):607-615. (Apr).
9. Bull-Otterson L., Feng W., Kirpich I., Wang Y., Qin X., Liu Y., et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One 2013, 8(1):4-13.
10. Burdyga G., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299(1):G63-G69. (Jul).
11. Butterworth R.F. Pathogenesis of Hepatic Encephalopathy and Brain Edema in Acute Liver Failure. J Clin Exp Hepatol [Internet] 2015, 5:S96-S103. Elsevier Ltd, (March, Available from: http://linkinghub.elsevier.com/retrieve/pii/S0973688314000103).
12. Conlon M.a, Bird A.R. The Impact of Diet and Lifestyle on Gut Microbiota and Human Health 2015, 17-44.
13. Cunningham J.T., Mifflin S.W., Gould G.G., Frazer A. Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology [Internet] 2008, 33(8):1884-1895. (Jul [cited 2014 Jul 31], Available from: http://www.ncbi.nlm.nih.gov/pubmed/17957222).
14. Dash S., Clarke G., Berk M., Jacka F.N. The gut microbiome and diet in psychiatry. Curr. Opin. Psychiatry [Internet] 2015, 28:1-6. (Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00001504-201501000-00002).
15. Dockray G.J. The versatility of the vagus. Physiol. Behav. 2009, 97(5):531-536. (Jul).
16. Dockray G.J. Cholecystokinin and Gut-Brain Signalling. Regul Pept [Internet] 2009, 155(1-3):6-10. Elsevier B.V., (Available from: http://dx.doi.org/10.1016/j.regpep.2009.03.015).
17. Dockray G.J. Gastrointestinal hormones and the dialogue between gut and brain. J. Physiol. [Internet] 2014, 00:1-15. (July 2013, Available from: http://www.ncbi.nlm.nih.gov/pubmed/24566540).
18. Dockray G.J., Burdyga G. Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance. Acta Physiol. (Oxf.) 2011, 201(3):313-321. (Mar).
19. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. A Meta-analysis of Cytokines in Major Depression. Biol Psychiatry [Internet] 2010, 67(5):446-457. Elsevier Inc, (Available from: http://dx.doi.org/10.1016/j.biopsych.2009.09.033).
20. Downs R., Perna J., Vitelli A., Cook D., Dhurjati P. Model-based hypothesis of gut microbe populations and gut/brain barrier permeabilities in the development of regressive autism. Med Hypotheses 2014, 83(6):649-655. 10.1016/j.mehy.2014.09.005.
21. Eeckhaut V., Machiels K., Perrier C., Romero C., Maes S., Flahou B., et al. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut [Internet] 2013, 62(12):1745-1752. (Available from: http://www.ncbi.nlm.nih.gov/pubmed/23263527).
22. El Aidy S., Dinan T.G., Cryan J.F. Immune modulation of the brain-gut-microbe axis. Front. Microbiol. 2014, 5:3-6. (April).
23. Farooq R.K., Isingrini E., Tanti A., Le Guisquet A.M., Arlicot N., Minier F., et al. Is Unpredictable Chronic Mild Stress (UCMS) a Reliable Model to Study Depression-induced Neuroinflammation?. Behav Brain Res [Internet] 2012, 231(1):130-137. Elsevier B.V., (Available from: http://dx.doi.org/10.1016/j.bbr.2012.03.020).
24. Fond G., Boukouaci W., Chevalier G., Regnault A., Eberl G., Hamdani N., et al. The "psychomicrobiotic": targeting microbiota in major psychiatric disorders: a systematic review. Pathol. Biol. (Paris) 2015, 35-42.
25. Foster J.a., McVey Neufeld K.A. Gut-Brain Axis: How the Microbiome Influences Anxiety and Depression. Trends Neurosci [Internet] 2013, 36(5):305-312. Elsevier Ltd, (Available from: http://dx.doi.org/10.1016/j.tins.2013.01.005).
26. Fraschini M., Demuru M., Puligheddu M., Floridia S., Polizzi L., Maleci A., et al. The Re-organization of Functional Brain Networks in Pharmacoresistant Epileptic Patients Who Respond to VNS. Neurosci Lett [Internet] 2014, 580:153-157. Elsevier Ireland Ltd, (Available from: http://www.sciencedirect.com/science/article/pii/S030439401400651X).
27. Freeman K., Brureau A., Vadigepalli R., Staehle M.M., Brureau M.M., Gonye G.E., et al. Temporal changes in innate immune signals in a rat model of alcohol withdrawal in emotional and cardiorespiratory homeostatic nuclei. J. Neuroinflammation [Internet] 2012, 9(1):97. (Jan [cited 2014 Jun 3], Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3411448&tool=pmcentrez&rendertype=abstract).
28. Freeman K., Staehle M.M., Vadigepalli R., Gonye G.E., Ogunnaike B.a., Hoek J.B., et al. Coordinated dynamic gene expression changes in the central nucleus of the amygdala during alcohol withdrawal. Alcohol Clin. Exp. Res. [Internet] 2013, 37(Suppl.1):E88-E100. (Jan [cited 2014 Jun 3], Available from: http://www.ncbi.nlm.nih.gov/pubmed/22827539).
29. Garcia-Oscos F., Peña D., Housini M., Cheng D., Lopez D., Borland M.S., et al. Vagal Nerve Stimulation Blocks Interleukin 6-dependent Synaptic Hyperexcitability Induced by Lipopolysaccharide-induced Acute Stress in the Rodent Prefrontal Cortex. Brain Behav Immun [Internet] 2015, 43:149-158. Elsevier Inc, (Available from: http://linkinghub.elsevier.com/retrieve/pii/S0889159114004127).
30. Gaykema R.P.A., Goehler L.E., Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav. Immun. 2004, 18(3):238-245. (May).
31. Gilpin N.W. Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors. Alcohol 2012, 46(4):329-337. (Jun).
32. Goehler L.E., Gaykema R.P.a, Hansen M.K., Anderson K., Maier S.F., Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 2000, 85:49-59.
33. Goehler L.E., Gaykema R.P.A., Opitz N., Reddaway R., Badr N., Lyte M. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav. Immun. 2005, 19(4):334-344. (Jul).
34. Goehler L.E., Park S.M., Opitz N., Lyte M., Gaykema R.P.A. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: Possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 2008, 22(3):354-366.
35. González H., Elgueta D., Montoya A., Pacheco R. Neuroimmune Regulation of Microglial Activity Involved in Neuroinflammation and Neurodegenerative Diseases. J Neuroimmunol [Internet] 2014, 274(1-2):1-13. Elsevier B.V., (Available from: http://dx.doi.org/10.1016/j.jneuroim.2014.07.012).
36. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 2008, 13:717-728.
37. Grenham S., Clarke G., Cryan J.F., Dinan T.G. Brain-gut-microbe communication in health and disease. Front. Physiol. 2011, 1-15. (2 DEC(December)).
38. 11C]PBR28 Positron Emission Tomography in Nonhuman Primates. Neuroimage [Internet] 2012, 63(1):232-239. Elsevier Inc, (Available from: http://dx.doi.org/10.1016/j.neuroimage.2012.06.055).
39. Hartmann P., Chen W.C., Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front. Physiol. 2012, 1-10. (3 OCT(October)).
40. Hsiao E.Y., McBride S.W., Hsien S., Sharon G., Hyde E.R., McCue T., et al. Microbiota Modulate Behavioral and Physiological Abnormalities Associated With Neurodevelopmental Disorders. Cell [Internet] 2013, 155(7):1451-1463. Elsevier Inc, (Available from: http://dx.doi.org/10.1016/j.cell.2013.11.024).
41. Jones K.a., Thomsen C. The Role of the Innate Immune System in Psychiatric Disorders. Mol Cell Neurosci [Internet] 2013, 53:52-62. Elsevier Inc, (Available from: http://dx.doi.org/10.1016/j.mcn.2012.10.002).
42. Kakiyama G., Hylemon P.B., Zhou H., Pandak W.M., Heuman D.M., Kang D.J., et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. [Internet] 2014, 306:G929-G937. (Available from: http://ajpgi.physiology.org/cgi/doi/10.1152/ajpgi.00315.2013).
43. Keita A.V., Söderholm J.D. The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol. Motil. 2010, 22:718-733.
44. Khairova R.a, Machado-Vieira R., Du J., Manji H.K. A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int. J. Neuropsychopharmacol. 2009, 12:561-578.
45. Klarer M., Arnold M., Gunther L., Winter C., Langhans W., Meyer U. Gut vagal afferents differentially modulate innate anxiety and learned fear. J. Neurosci. [Internet] 2014, 34(21):7067-7076. (Available from: http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.0252-14.2014).
46. Koo J.W., Duman R.S. Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression. Curr. Opin. Investig. Drugs 2009, 10(7):664-671.
47. Koob G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biol. Psychiatry 1999, 46:1167-1180.
48. Koob G.F. The Role of CRF and CRF-related Peptides in the Dark Side of Addiction. Brain Res 2010, 1314:3-14. Elsevier B.V., (Feb).
49. Koob G.F. The dark side of emotion: the addiction perspective. Eur. J. Pharmacol. 2015, 753:73-87.
50. Kunze W.a., Mao Y.K., Wang B., Huizinga J.D., Ma X., Forsythe P., et al. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J. Cell. Mol. Med. 2009, 13(8):2261-2270.
51. Maier S.F., Goehler L.E., Fleshner M., Watkins L.R. The role of the vagus nerve in cytokine-to-brain communication. Ann. N. Y. Acad. Sci. U. S. 1998, 840:289-300. (May).
52. Malaguarnera G. Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives. World J. Gastroenterol. [Internet] 2014, 20(44):16639. (Available from: http://www.wjgnet.com/1007-9327/full/v20/i44/16639.htm).
53. Maniscalco J.W., Kreisler A.D., Rinaman L. Satiation and stress-induced hypophagia: examining the role of hindbrain neurons expressing prolactin-releasing peptide or glucagon-like peptide 1. Front. Neurosci. 2012, 6:1-17. (January).
54. Mayer E.a Gut Feelings: The Emerging Biology of Gut-Brain Communication. Nat Rev Neurosci [Internet] 2011, 12:453-466. Nature Publishing Group, (August, Available from: http://dx.doi.org/10.1038/nrn3071).
55. Mihaylova S., Killian A., Mayer K., Pullamsetti S.S., Schermuly R., Rosengarten B. Effects of anti-inflammatory vagus nerve stimulation on the cerebral microcirculation in endotoxinemic rats. J. Neuroinflammation [Internet] 2012, 9(1):183. (Available from: http://www.jneuroinflammation.com/content/9/1/183).
56. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Soc. Biol. Psychiatry 2009, 65(9):732-741. Biol Psychiatry [Internet], (Available from: http://dx.doi.org/10.1016/j.biopsych.2008.11.029).
57. Mössner R., Mikova O., Koutsilieri E., Saoud M., Ehlis A.-C., Müller N., et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J. Biol. Psychiatry 2007, 8(3):141-174.
58. Mravec B. The Role of the Vagus Nerve in Stroke. Auton Neurosci Basic Clin [Internet] 2010, 158(1-2):8-12. Elsevier B.V., (Available from: http://dx.doi.org/10.1016/j.autneu.2010.08.009).
59. Mutlu E.a., Gillevet P.M., Rangwala H., Sikaroodi M., Naqvi A., Engen P.a, et al. Colonic microbiome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302:G966-G978.
60. Nemani K., Hosseini Ghomi R., McCormick B., Fan X. Schizophrenia and the Gut-Brain Axis. Prog Neuro-Psychopharmacology Biol Psychiatry [Internet] 2015, 56:155-160. Elsevier Inc, (Available from: http://linkinghub.elsevier.com/retrieve/pii/S0278584614001687).
61. Nishino R., Mikami K., Takahashi H., Tomonaga S., Furuse M., Hiramoto T., et al. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol. Motil. 2013, 25(6):521-528. (Jun).
62. O'Sullivan J.B., Ryan K.M., Harkin A., Connor T.J. Noradrenaline Reuptake Inhibitors Inhibit Expression of Chemokines IP-10 and RANTES and Cell Adhesion Molecules VCAM-1 and ICAM-1 in the CNS Following a Systemic Inflammatory Challenge. J Neuroimmunol [Internet] 2010, 220(1-2):34-42. Elsevier B.V., (Available from: http://dx.doi.org/10.1016/j.jneuroim.2009.12.007).
63. Oshinsky M.L., Murphy A.L., Hekierski H., Cooper M., Simon B.J. Noninvasive Vagus Nerve Stimulation as Treatment for Trigeminal Allodynia. Pain [Internet] 2014, 155(5):1037-1042. International Association for the Study of Pain, (May [cited 2014 Sep 9], Available from: http://www.ncbi.nlm.nih.gov/pubmed/24530613).
64. Paulus M.P., Stein M.B. Interoception in anxiety and depression. Brain Struct. Funct. 2010, 1-13.
65. Perez S.M., Carreno F.R., Frazer A., Lodge D.J. Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia. J. Neurosci. [Internet] 2014, 34(28):9261-9267. (Available from: http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.0588-14.2014).
66. Perez-Burgos A., Wang B., Mao Y.-K., Mistry B., McVey Neufeld K.-A., Bienenstock J., et al. Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304(2):G211-G220. (Jan).
67. Phelix C.F., Liposits Z., Paull W.K. Catecholamine-CRF synaptic interaction in a septal bed nucleus: afferents of neurons in the bed nucleus of the stria terminalis. Brain Res. Bull. U. S. 1994, 33(1):109-119.
68. Reichenberger E.R., Alexander G.M., Perreault M.J., Russell J.a., Schwartzman R.J., Hershberg U., et al. Establishing a relationship between bacteria in the human gut and complex regional pain syndrome. Brain Behav. Immun. [Internet] 2013, 29:62-69. (Available from: http://dx.doi.org/10.1016/j.bbi.2012.12.005).
69. Retson T.a., Hoek J.B., Sterling R.C., Van Bockstaele E.J. Amygdalar neuronal plasticity and the interactions of alcohol, sex, and stress. Brain Struct. Funct. 2014, [Epub ahead of print].
70. Reyes B.a S., Van Bockstaele E.J. Divergent projections of catecholaminergic neurons in the nucleus of the solitary tract to limbic forebrain and medullary autonomic brain regions. Brain Res. 2006, 1117(1):69-79.
71. Rhee S.H., Pothoulakis C., Mayer E.a Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 2009, 6(5):306-314.
72. Rinaman L. Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R222-R235.
73. Sakanaka M., Shibasaki T., Lederis K. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat. Brain Res. 1986, 382:213-238.
74. Scheperjans F., Aho V., Pereira P.a.B., Koskinen K., Paulin L., Pekkonen E., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. [Internet] 2015, 30(3):350-358. (Available from: http://doi.wiley.com/10.1002/mds.26069).
75. Severance E.G., Yolken R.H., Eaton W.W. Autoimmune Diseases, Gastrointestinal Disorders and the Microbiome in Schizophrenia: More Than a Gut Feeling. Schizophr Res [Internet] 2014, Elsevier B.V., (Available from: http://dx.doi.org/10.1016/j.schres.2014.06.027).
76. Shah A., Carreno F.R., Frazer A. Therapeutic Modalities for Treatment Resistant Depression : Focus on Vagal Nerve Stimulation and Ketamine 2014, 12(2):83-93.
77. Skinner R.a., Gibson R.M., Rothwell N.J., Pinteaux E., Penny J.I. Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br. J. Pharmacol. 2009, 156:1115-1123.
78. Slyepchenko A., Carvalho A.F., Cha D.S., Kasper S., McIntyre R.S. Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders. CNS Neurol. Disord. Drug Targets United Arab Emirates 2014, 13(10):1770-1786.
79. Tillisch K., Labus J., Kilpatrick L., Jiang Z., Stains J., Ebrat B., et al. Consumption of Fermented Milk Product With Probiotic Modulates Brain Activity. Gastroenterology [Internet] 2013, 144(7). Elsevier Inc, (1394-401.e4, Available from: http://dx.doi.org/10.1053/j.gastro.2013.02.043).
80. Toh M.C., Allen-vercoe E. The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts. Microb. Ecol. Health Dis. 2015, 1:1-7.
81. Van Hemert S., Breedveld A.C., Rovers J.M., Vermeiden J.P., Witteman B.J., Smits M.G., et al. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications. Front. Neurol. [Internet] 2014, 5:1-7. (November, Available from: http://journal.frontiersin.org/journal/10.3389/fneur.2014.00241/abstract).
82. Vonck K., Raedt R., Naulaerts J., De Vogelaere F., Thiery E., Van Roost D., et al. Vagus Nerve Stimulation. . .25years Later! What Do We Know About the Effects on Cognition?. Neurosci Biobehav Rev [Internet] 2014, 45C:63-71. Elsevier Ltd, (Available from: http://www.ncbi.nlm.nih.gov/pubmed/24858008).
83. Waghray A., Waghray N., Kanna S., Mullen K. Optimal treatment of hepatic encephalopathy. Minerva Gastroenterol. Dietol. Italy 2014, 60(1):55-70. (Mar).
84. Walker F.R. A Critical Review of the Mechanism of Action for the Selective Serotonin Reuptake Inhibitors: Do These Drugs Possess Anti-inflammatory Properties and How Relevant Is This in the Treatment of Depression?. Neuropharmacology [Internet] 2013, 67:304-317. Elsevier Ltd, (Available from: http://dx.doi.org/10.1016/j.neuropharm.2012.10.002).
85. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., Valdez G.R., Ben-Shahar O., Angeletti S., Richter R.R. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci. 2001, 937:1-26. (Jun).
86. Weston B., Fogal B., Cook D., Dhurjati P. An agent-based modeling framework for evaluating hypotheses on risks for developing autism: effects of the gut microbial environment. Med. Hypotheses 2015, 84(4):395-401. (Jan).
87. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.a, Peters E.C., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(10):3698-3703.
88. Zheng H., Cai L., Rinaman L. Distribution of glucagon-like peptide 1-immunopositive neurons in human caudal medulla. Brain Struct. Funct. 2014, 1-7.
89. Zorrilla E.P., Logrip M.L., Koob G.F. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front. Neuroendocrinol. 2014, 35(2):234-244. (Apr).